Cargando…
The impact of 30 ml/kg hydroxyethyl starch 130/0.4 vs hydroxyethyl starch 130/0.42 on coagulation in patients undergoing abdominal surgery
BACKGROUND & OBJECTIVES: Hydroxyethyl starches (HES) 130/0.4 (Voluven®) and 130/0.42 (Venofundin®) impair coagulation less than older HES solutions with higher molecular weight and molar substitution. Thus, these may be used in high doses up to 50 ml/kg/day. The aim of this study was to investig...
Autores principales: | Staikou, Chryssoula, Paraskeva, Anteia, Fassoulaki, Argyro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510891/ https://www.ncbi.nlm.nih.gov/pubmed/23041738 |
Ejemplares similares
-
Is hydroxyethyl starch 130/0.4 safe?
por: Haase, Nicolai, et al.
Publicado: (2012) -
Hydroxyethyl starch 200/0.5 induces more renal macrophage infiltration than hydroxyethyl starch 130/0.42 in an isolated renal perfusion model
por: Hüter, L, et al.
Publicado: (2008) -
Low-quality Trials as a Source of Heterogeneity in the Association of Hydroxyethyl Starch 130/0.4 or 0.42 with Excess Mortality in Sepsis
por: Wiedermann, Christian J
Publicado: (2016) -
Assessment of coagulation with 6% hydroxyethyl starch 130/0.4 in cesarean section
por: Oh, Chung-Sik, et al.
Publicado: (2012) -
Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement is safe and effective in children
por: Suempelmann, R, et al.
Publicado: (2008)